Publications by authors named "Rogelio Trejo"
Article Synopsis
- Lung cancer remains the top cause of cancer-related deaths globally, with this study focusing on the impacts of stage IV non-small cell lung cancer (NSCLC) in Mexico's healthcare system.
- The research involved 188 patients diagnosed with stage IV NSCLC, analyzing treatments and outcomes at various healthcare centers while also assessing economic factors like treatment costs and productivity losses among patients and caregivers.
- Findings indicated high treatment costs, with public sector costs averaging MXN1,001,579 per patient and private sector costs around MXN2,140,604, alongside significant productivity losses for both patients (up to 335 days/year) and caregivers (13-30 days/year).
gene fusions have been detected in more than 25 types of tumors and their prevalence is approximately 0.3% in solid tumors. This low prevalence makes identifying patients who could benefit from TRK inhibitors a considerable challenge.
View Article and Find Full Text PDF